Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BYObesity pillars

Hope, hype, and high costs: Navigating glucagon-like Peptide-1 based therapy initiation among young adults

  • Sourav Das Gupta1
  • Jaqueline Krystel Loubeau1
  • Antara Swarnali Priyanka2
  • Yajaira A. Cabrera Tineo3
  • Janet Diaz-Martinez4
  • Michelle M. Hospital5
  • Mariana Sanchez1
  • Rumi Agarwal1
5 affiliations
  1. 1Department of Health Promotion and Disease Prevention, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, Miami, FL, 33199, USA
  2. 2Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, Miami, FL, 33199, USA
  3. 3Center for Research on US Latino HIV/AIDS and Drug Abuse (CRUSADA), Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, Miami, FL, 33199, USA
  4. 4Department of Dietetics and Nutrition, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, Miami, FL, 33199, USA
  5. 5Department of Biostatistics, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, Miami, FL, 33199, USA
Read full textPDFCite

Related

  1. Initiation of Glucagon-Like Peptide-1 Receptor Agonist Therapy and Lifestyle Modifications for Morbid Obesity in a Patient With Paroxysmal Atrial Fibrillation, Severe Osteoarthritis, and Obstructive Sleep Apnea: A Case Report
    Brian Morris
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
    Wares Jalil
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Association of Glucagon-like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors with Tuberculosis and Mortality in Adults with Diabetes
    Chun-Hsiang Hsu, Renin Chang, Chiu-Fan Chen +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMC
  4. Cardiovascular–kidney–metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy
    Fengzhao Liu, Zihan Xu, Wenru Wang +3
    Frontiers in Cell and Developmental BiologyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  5. Digital and algorithmic strategies for guideline-directed medical therapy initiation and up-titration in adults with heart failure with reduced ejection fraction: a systematic review
    Naveen Gautam, Saroj GC, Preeti Kharel +2
    Annals of medicine and surgery (2012)Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{gupta2026hope,
  title = {{Hope, hype, and high costs: Navigating glucagon-like Peptide-1 based therapy initiation among young adults}},
  author = {Sourav Das Gupta and Jaqueline Krystel Loubeau and Antara Swarnali Priyanka and Yajaira A. Cabrera Tineo and Janet Diaz-Martinez and Michelle M. Hospital and Mariana Sanchez and Rumi Agarwal},
  journal = {Obesity pillars},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13653475},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Hope, hype, and high costs: Navigating glucagon-like Peptide-1 based therapy initiation among young adults
AU  - Sourav Das Gupta
AU  - Jaqueline Krystel Loubeau
AU  - Antara Swarnali Priyanka
AU  - Yajaira A. Cabrera Tineo
AU  - Janet Diaz-Martinez
AU  - Michelle M. Hospital
AU  - Mariana Sanchez
AU  - Rumi Agarwal
PY  - 2026
DA  - 2026/09/28
JO  - Obesity pillars
UR  - https://europepmc.org/article/PMC/PMC13653475
SN  - 2667-3681
ER  -